一名接受白细胞介素-17抑制剂治疗的患者中与肌肉特异性激酶抗体相关的重症肌无力 - Suppr

Suppr

超能文献

Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor.

作者信息

Papi Claudia, Granata Giuseppe, Galluzzo Marco, Iorio Raffaele

机构信息

Università Cattolica del Sacro Cuore, Rome, Italy.

Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

出版信息

Neurol Sci. 2023 Mar;44(3):1105-1107. doi: 10.1007/s10072-022-06498-7. Epub 2022 Nov 11.

DOI:10.1007/s10072-022-06498-7

PMID:36357816

Abstract

摘要

相似文献

Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor.

Neurol Sci. 2023 Mar;44(3):1105-1107. doi: 10.1007/s10072-022-06498-7. Epub 2022 Nov 11.

Interleukin-17 inhibitors in myasthenia gravis: really bad or maybe good?

Neurol Sci. 2023 Aug;44(8):2981-2982. doi: 10.1007/s10072-023-06796-8. Epub 2023 Apr 11.

Early-onset acquired myasthenia gravis secondary to anti-muscle-specific kinase autoantibodies.

J Child Neurol. 2014 Jan;29(1):108-10. doi: 10.1177/0883073812467689. Epub 2012 Dec 12.

Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Neurol Clin. 2018 May;36(2):293-310. doi: 10.1016/j.ncl.2018.01.004.

Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG).

Clin Exp Immunol. 2019 Aug;197(2):214-221. doi: 10.1111/cei.13302. Epub 2019 Apr 12.

Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.

Brain. 2012 Apr;135(Pt 4):1081-101. doi: 10.1093/brain/aws025. Epub 2012 Mar 6.

Myasthenia gravis, autoantibodies, and HL-A antigens.

Br Med J. 1974 Jan 26;1(5899):131-3. doi: 10.1136/bmj.1.5899.131.

Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.

Curr Opin Neurol. 2005 Oct;18(5):519-25. doi: 10.1097/01.wco.0000180660.57801.3f.

IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.

Neurology. 1984 Aug;34(8):1094-6. doi: 10.1212/wnl.34.8.1094.

Mouse models of myasthenia gravis.

Curr Pharm Des. 2015;21(18):2468-86. doi: 10.2174/1381612821666150316123233.

引用本文的文献

Non-coding RNA and its network in the pathogenesis of Myasthenia Gravis.

Front Mol Biosci. 2024 Sep 10;11:1388476. doi: 10.3389/fmolb.2024.1388476. eCollection 2024.

Response to Letter to the Editor by Kim et al.

Neurol Sci. 2023 Dec;44(12):4535. doi: 10.1007/s10072-023-06989-1. Epub 2023 Aug 3.

Interleukin-17 inhibitors in myasthenia gravis: really bad or maybe good?

Neurol Sci. 2023 Aug;44(8):2981-2982. doi: 10.1007/s10072-023-06796-8. Epub 2023 Apr 11.

Inflammation and autoimmune myasthenia gravis.

Front Immunol. 2023 Jan 30;14:1110499. doi: 10.3389/fimmu.2023.1110499. eCollection 2023.

本文引用的文献

Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis.

J Neuroimmunol. 2020 Aug 15;345:577279. doi: 10.1016/j.jneuroim.2020.577279. Epub 2020 May 27.

Pattern of ocular involvement in myasthenia gravis with MuSK antibodies.

J Neurol Neurosurg Psychiatry. 2017 Sep;88(9):761-763. doi: 10.1136/jnnp-2017-315782. Epub 2017 Jun 10.

Elevated plasma interleukin-17A in a subgroup of Myasthenia Gravis patients.

Cytokine. 2016 Feb;78:44-6. doi: 10.1016/j.cyto.2015.06.011. Epub 2015 Nov 28.

Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.

J Autoimmun. 2014 Aug;52:130-8. doi: 10.1016/j.jaut.2013.12.005. Epub 2013 Dec 28.

Increased serum interleukin-17 levels in patients with myasthenia gravis.

Muscle Nerve. 2011 Aug;44(2):278-80. doi: 10.1002/mus.22070.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor.

Neurol Sci. 2023 Mar;44(3):1105-1107. doi: 10.1007/s10072-022-06498-7. Epub 2022 Nov 11.

Interleukin-17 inhibitors in myasthenia gravis: really bad or maybe good?

Neurol Sci. 2023 Aug;44(8):2981-2982. doi: 10.1007/s10072-023-06796-8. Epub 2023 Apr 11.

Early-onset acquired myasthenia gravis secondary to anti-muscle-specific kinase autoantibodies.

J Child Neurol. 2014 Jan;29(1):108-10. doi: 10.1177/0883073812467689. Epub 2012 Dec 12.

Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Neurol Clin. 2018 May;36(2):293-310. doi: 10.1016/j.ncl.2018.01.004.

Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG).

Clin Exp Immunol. 2019 Aug;197(2):214-221. doi: 10.1111/cei.13302. Epub 2019 Apr 12.

Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.

Brain. 2012 Apr;135(Pt 4):1081-101. doi: 10.1093/brain/aws025. Epub 2012 Mar 6.

Myasthenia gravis, autoantibodies, and HL-A antigens.

Br Med J. 1974 Jan 26;1(5899):131-3. doi: 10.1136/bmj.1.5899.131.

Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.

Curr Opin Neurol. 2005 Oct;18(5):519-25. doi: 10.1097/01.wco.0000180660.57801.3f.

IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.

Neurology. 1984 Aug;34(8):1094-6. doi: 10.1212/wnl.34.8.1094.

Mouse models of myasthenia gravis.

Curr Pharm Des. 2015;21(18):2468-86. doi: 10.2174/1381612821666150316123233.

引用本文的文献

Non-coding RNA and its network in the pathogenesis of Myasthenia Gravis.

Front Mol Biosci. 2024 Sep 10;11:1388476. doi: 10.3389/fmolb.2024.1388476. eCollection 2024.

Response to Letter to the Editor by Kim et al.

Neurol Sci. 2023 Dec;44(12):4535. doi: 10.1007/s10072-023-06989-1. Epub 2023 Aug 3.

Interleukin-17 inhibitors in myasthenia gravis: really bad or maybe good?

Neurol Sci. 2023 Aug;44(8):2981-2982. doi: 10.1007/s10072-023-06796-8. Epub 2023 Apr 11.

Inflammation and autoimmune myasthenia gravis.

Front Immunol. 2023 Jan 30;14:1110499. doi: 10.3389/fimmu.2023.1110499. eCollection 2023.

本文引用的文献

Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis.

J Neuroimmunol. 2020 Aug 15;345:577279. doi: 10.1016/j.jneuroim.2020.577279. Epub 2020 May 27.

Pattern of ocular involvement in myasthenia gravis with MuSK antibodies.

J Neurol Neurosurg Psychiatry. 2017 Sep;88(9):761-763. doi: 10.1136/jnnp-2017-315782. Epub 2017 Jun 10.

Elevated plasma interleukin-17A in a subgroup of Myasthenia Gravis patients.

Cytokine. 2016 Feb;78:44-6. doi: 10.1016/j.cyto.2015.06.011. Epub 2015 Nov 28.

Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.

J Autoimmun. 2014 Aug;52:130-8. doi: 10.1016/j.jaut.2013.12.005. Epub 2013 Dec 28.

Increased serum interleukin-17 levels in patients with myasthenia gravis.

Muscle Nerve. 2011 Aug;44(2):278-80. doi: 10.1002/mus.22070.